To his knowledge, this was the first-ever randomized, head-to-head comparison of the effectiveness of a physical therapy regimen versus
corticosteroid injections for knee OA.
[USA], Feb 20 (ANI): With help from a dozen clinical variables, researchers have been able to identify using machine learning techniques, which of their patients with severe asthma are likely to benefit from treatment with systemic
corticosteroids -- and which might only suffer their side effects.
Intra-articular
corticosteroid therapy is a common clinical practice used in the management of osteoarthritis.7,8,12,13 This therapy is also part of the recommendations made by the American College of Rheumatology (ACR) for the treatment of osteoarthritis, and of the Knee and Osteoarthritis Research Society International(OARSI) guidelines for the non-surgical management of KOA.13,18 But its effects are limited for only 1-4 week.2,7,8,11,12 Intra-articular injection of a combination of local anaesthetic and
corticosteroids in KOA is also mentioned in literature.
and few other studies have found no significant improvement with physical therapy, and instead they suggested GH intra-articular (IA)
corticosteroid injection having much beneficial effects as compared to other form of treatment10-12.
Corticosteroids play a vital role in the treatment of many diseases including skin.
At this point, the decision was made to proceed with intravitreal
corticosteroid therapy.
The obvious individual differences of corticosteroid-induced ONFH may be the combined effect of
corticosteroid on multisystem underlying diseases and host susceptibility.
Infants born already 3 hours after
corticosteroid administration to the mother had significantly lower mortality than those not exposed to the treatment, and
corticosteroid administration 6 to 12 hours before birth was associated with halved risks of infant death.
A sixty-year-old right hand dominant woman with a history of right small finger stenosing tenosynovitis and left thumb carpometacarpal joint arthritis presented for
corticosteroid injections of both hands.
A recent meta-analysis of 3 trials including 3,200 women at high risk for preterm delivery at 34 0/7 to 36 6/7 weeks of gestation reported that the
corticosteroid administration reduced newborn risk for transient tachypnea of the newborn (relative risk [RR], 0.72; 95% confidence interval [CI], 0.56-0.92), severe respiratory distress syndrome (RR, 0.60; 95% CI, 0.33-0.94), and use of surfactant (RR, 0.61; 95% CI, 0.38-0.99).
Most clinicians recommended either an oral, parenteral, or high-potency topical
corticosteroid, and some also recommended an oral antihistamine, usually diphenhydramine.
In our study, majority of topical
corticosteroid were prescribed in combination (42%).